Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Venous Thromboembolism 3Neoplasms 3Venous Thrombosis 2Thromboembolism 2Pulmonary Embolism 2Multiple Myeloma 2Lymphoma 2Lung Neoplasms 2Colorectal Neoplasms 2Vascular Diseases 1Urogenital Neoplasms 1Prostatic Neoplasms 1Myeloproliferative Disorders 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Leukemia 1Intestinal Neoplasms 1Hemostatic Disorders 1Digestive System Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Dalteparin 7apixaban 6Rivaroxaban 3edoxaban 2bemiparin 2Warfarin 2Tinzaparin 2Fondaparinux 2Enoxaparin 2Dabigatran 2Phenprocoumon 1Nephrectomy 1Nadroparin 1Heparin, Low-Molecular-Weight 1Heparin 1Aspirin 1Acetylcysteine 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Pulmonary Embolism × Tinzaparin × Clear all
NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

NCT00967148 2014-10-22

PERI-OP

Ottawa Hospital Research Institute

Phase NA Completed
18 enrolled

Neoplasms, Pulmonary Embolism, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡